Evidence map›Paper›PMID 26502721›Full record

ArticleMicrobiome2015

Microbiomes of the dust particles collected from the International Space Station and Spacecraft Assembly Facilities.

Aleksandra Checinska, Alexander J Probst, Parag Vaishampayan, James R White, Deepika Kumar, Victor G Stepanov, George E Fox, Henrik R Nilsson, Duane L Pierson, Jay Perry and 1 more

Open access · goldAbstract read
In one paragraph

Article in Microbiome, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 109 papers.

0numbers the graph read from it
0cells of the map it votes in
109citing papers in PubMed
10.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

109 citing papers in PubMed, 237 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article

49 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 8 institutions in 2 countries.

Aleksandra ChecinskaJet Propulsion Laboratory, Biotechnology and Planetary Protection Group, California Institute of Technology, M/S 89-2 4800 Oak Grove Dr., Pasadena, CA, 91109, USA.
Alexander J ProbstDepartment of Earth and Planetary Sciences, University of California, Berkeley, CA, USA.
Parag VaishampayanJet Propulsion Laboratory, Biotechnology and Planetary Protection Group, California Institute of Technology, M/S 89-2 4800 Oak Grove Dr., Pasadena, CA, 91109, USA.
James R WhiteResphera Biosciences, Baltimore, MD, USA.
Deepika KumarDepartment of Biology and Biochemistry, University of Houston, Houston, TX, USA.
Victor G StepanovDepartment of Biology and Biochemistry, University of Houston, Houston, TX, USA.
George E FoxDepartment of Biology and Biochemistry, University of Houston, Houston, TX, USA.
Henrik R NilssonDepartment of Biological and Environmental Sciences, University of Gothenburg, Gothenburg, Sweden.
Duane L PiersonJohnson Space Center, Houston, TX, USA.
Jay PerryMarshall Space Flight Center, Huntsville, AL, USA.
Kasthuri VenkateswaranJet Propulsion Laboratory, Biotechnology and Planetary Protection Group, California Institute of Technology, M/S 89-2 4800 Oak Grove Dr., Pasadena, CA, 91109, USA. kjvenkat@jpl.nasa.gov.
University of Houston · USJet Propulsion Laboratory · USCalifornia Institute of Technology · USJohnson Space Center · USMarshall Space Flight Center · USResphera Biosciences · USUniversity of California, Berkeley · USUniversity of Gothenburg · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe International Space Station (ISS) is a unique built environment due to the effects of microgravity, space radiation, elevated carbon dioxide levels, and especially continuous human habitation. Understanding the composition of the ISS microbial community will facilitate further development of safety and maintenance practices. The primary goal of this study was to characterize the viable microbiome of the ISS-built environment. A second objective was to determine if the built environments of Earth-based cleanrooms associated with space exploration are an appropriate model of the ISS environment.

resultsSamples collected from the ISS and two cleanrooms at the Jet Propulsion Laboratory (JPL, Pasadena, CA) were analyzed by traditional cultivation, adenosine triphosphate (ATP), and propidium monoazide-quantitative polymerase chain reaction (PMA-qPCR) assays to estimate viable microbial populations. The 16S rRNA gene Illumina iTag sequencing was used to elucidate microbial diversity and explore differences between ISS and cleanroom microbiomes. Statistical analyses showed that members of the phyla Actinobacteria, Firmicutes, and Proteobacteria were dominant in the samples examined but varied in abundance. Actinobacteria were predominant in the ISS samples whereas Proteobacteria, least abundant in the ISS, dominated in the cleanroom samples. The viable bacterial populations seen by PMA treatment were greatly decreased. However, the treatment did not appear to have an effect on the bacterial composition (diversity) associated with each sampling site.

conclusionsThe results of this study provide strong evidence that specific human skin-associated microorganisms make a substantial contribution to the ISS microbiome, which is not the case in Earth-based cleanrooms. For example, Corynebacterium and Propionibacterium (Actinobacteria) but not Staphylococcus (Firmicutes) species are dominant on the ISS in terms of viable and total bacterial community composition. The results obtained will facilitate future studies to determine how stable the ISS environment is over time. The present results also demonstrate the value of measuring viable cell diversity and population size at any sampling site. This information can be used to identify sites that can be targeted for more stringent cleaning. Finally, the results will allow comparisons with other built sites and facilitate future improvements on the ISS that will ensure astronaut health.

Indexed as

Air MicrobiologyDustMicrobiotaSpacecraftArchaeaBacteriaBiodiversityCluster AnalysisEnvironment, ControlledFungiHumansMetagenomeRNA, Ribosomal, 16SDustRNA, Ribosomal, 16S

Identifiers

PMID26502721
PMCPMC4624184
OpenAlexW2124790317

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.